Savani, SamiraOnbaşlı, KübraGündüz, ErenAydındoğan, EdaErkısa, MerveMuti, AbdullahKhan, MinahilSennaroglu, AlphanUlukaya, EnginYağcı Acar, HavvaKölemen, Safacan2022-03-242022-03-242022Savani S, Onbasli K, Gunduz H, Aydındogan E, Erkısa M, Muti A, Khan M, Sennaroglu A, Ulukaya E, Yagci Acar H, Kolemen S. Development of a cysteine responsive chlorinated hemicyanine for image-guided dual phototherapy. Bioorg Chem. 2022 Mar 17;122:105725.https://doi.org/10.1016/j.bioorg.2022.105725https://hdl.handle.net/20.500.12713/2583A cysteine (Cys) activatable chlorinated hemicyanine (Cl-Cys) was introduced as a tumour selective image-guided dual phototherapy agent. Cl-Cys exhibited a significant turn on response in its near-IR emission signal and activated its singlet oxygen generation as well as photothermal conversion potentials upon reacting with Cys. The laser irradiation of Cl-Cys induced significant cell death in cancer cells with high Cys level, while it stayed deactivated and non-emissive in a healthy cell line. A profound synergistic PDT/PTT effect was observed at high doses. Remarkably, Cl-Cys marks the first ever example of Cys-responsive small organic-based therapeutic agent and holds a great promise to develop new activity-based photosensitizers for dual phototherapy action.eninfo:eu-repo/semantics/closedAccessCancerCysteineHemicyaninePhotosensitizersPhototherapyTheranosticsArticle35316664WOS:0007887185000042-s2.0-85126525592Q110.1016/j.bioorg.2022.105725N/A